Skip to content
OpenCapital
Get started

Microbot Medical MBOT Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum

Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum at other companies

CHE
ChemedCHE
3.5%-0.5pp
OS Therapies logo
OS TherapiesOSTX
3.8%—
Belden logo
BeldenBDC
4%-0.4pp
CBAK Energy Technology, Inc. logo
CBAK Energy Technology, Inc.CBAT
3.5%0.0pp
RFL
Rafael Holdings, Inc.RFL
3.7%—
Norwood Financial logo
Norwood FinancialNWFL
4.1%-0.3pp

Other financials

Income statement

See full
Revenue$105.0K—
Gross profit$2.0K—
Operating income-$4.3M-43.0%
Net income-$3.7M-41.1%
EPS (diluted)-$0.05+37.5%

Balance sheet

See full
Cash & equivalents$3.7M+13.7%
Total debt$898.0K+551%
Total equity$74.1M+156%
Total assets$78.1M+153%

Cash flow

See full
Operating cash flow-$5.1M-75.8%
CapEx$108.0K+731%
Free cash flow-$5.2M-78.8%

Valuation

See full
Market cap$128.28M+36.1%
Enterprise value$125.53M+39.0%
P/S674.3×—

Profitability

See full
Operating margin25,292.9%—
Net margin-3,669.9%—
FCF margin-852.8%—

Returns & leverage

See full
Return on equity-27.6%-10.2pp
Debt / equity0×0.0×
Current ratio22.6×+6.4×

Where this comes from

Reported directly by Microbot Medical in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum.

The official record: Microbot Medical’s 10-K, filed March 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Microbot Medical's share based compensation arrangement by share based payment award fair value assumptions risk free interest rate maximum.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Microbot Medical's share based compensation arrangement by share based payment award fair value assumptions risk free interest rate maximum?
Microbot Medical (MBOT) reported share based compensation arrangement by share based payment award fair value assumptions risk free interest rate maximum of 4.4% in Q4 2025.
How has Microbot Medical's share based compensation arrangement by share based payment award fair value assumptions risk free interest rate maximum changed year-over-year?
Microbot Medical's share based compensation arrangement by share based payment award fair value assumptions risk free interest rate maximum increased by 2.3% year-over-year, from 4.3% to 4.4%.
What does share based compensation arrangement by share based payment award fair value assumptions risk free interest rate maximum mean?
The upper bound of the risk-free interest rate used to discount the expected future cash flows or exercise prices of share-based payment awards. This rate reflects the maximum yield environment applied to the valuation model for equity incentives. It is a necessary component for calculating the fair value of compensation granted to employees and directors.